(Q33392436)

English

A randomized study of pegylated liposomal doxorubicin versus continuous-infusion doxorubicin in elderly patients with acute lymphoblastic leukemia: the GRAALL-SA1 study

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

A randomized study of pegylated liposomal doxorubicin versus continuous-infusion doxorubicin in elderly patients with acute lymphoblastic leukemia: the GRAALL-SA1 study (English)

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

1 reference

based on heuristic

inferred from title

lymphoblastic leukemia

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

Martine Escoffre-Barbe

7

object named as

Martine Escoffre-Barbe

0 references

Marina Lafage-Pochitaloff

17

object named as

Marina Lafage-Pochitaloff

0 references

Mathilde Hunault-Berger

1

object named as

Mathilde Hunault-Berger

0 references

object named as

Norbert Ifrah

19

0 references

20

object named as

Hervé Dombret

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

author name string

Thibaut Leguay

2

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Xavier Thomas

3

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Ollivier Legrand

4

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Françoise Huguet

5

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Caroline Bonmati

6

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Laurence Legros

8

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Pascal Turlure

9

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Patrice Chevallier

10

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Fabrice Larosa

11

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Frederic Garban

12

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Oumedaly Reman

13

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Philippe Rousselot

14

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Nathalie Dhédin

15

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

André Delannoy

16

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Marie Christine Béné

18

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Group for Research on Adult Acute Lymphoblastic Leukemia (GRAALL)

21

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

language of work or name

1 reference

based on heuristic

inferred from title

publication date

22 October 2010

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

96

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

2

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

245-252

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Pegylated liposomal doxorubicin, vincristine, and dexamethasone provide significant reduction in toxicity compared with doxorubicin, vincristine, and dexamethasone in patients with newly diagnosed multiple myeloma: a Phase III multicenter randomized

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3031692

21 June 2018

Acute lymphoblastic leukaemia in elderly patients: biological characteristics and therapeutic approaches

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3031692

21 June 2018

Cardiac profiles of liposomal anthracyclines: greater cardiac safety versus conventional doxorubicin?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3031692

21 June 2018

Reduced cardiotoxicity and comparable efficacy in a phase III trial of pegylated liposomal doxorubicin HCl (CAELYX/Doxil) versus conventional doxorubicin for first-line treatment of metastatic breast cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3031692

21 June 2018

Glucocorticoids and invasive fungal infections

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3031692

21 June 2018

Acute lymphoblastic leukemia in the elderly

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3031692

21 June 2018

Pegylated liposomal doxorubicin in the CHOP regimen for older patients with aggressive (stages III/IV) non-Hodgkin's lymphoma.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3031692

21 June 2018

Comparison of Escherichia coli-asparaginase with Erwinia-asparaginase in the treatment of childhood lymphoid malignancies: results of a randomized European Organisation for Research and Treatment of Cancer-Children's Leukemia Group phase 3 trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3031692

21 June 2018

Daunorubicin continuous infusion induces more toxicity than bolus infusion in acute lymphoblastic leukemia induction regimen: a randomized study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3031692

21 June 2018

A randomized controlled trial of filgrastim during remission induction and consolidation chemotherapy for adults with acute lymphoblastic leukemia: CALGB study 9111.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3031692

21 June 2018

Pegylated-liposomal doxorubicin versus doxorubicin, bleomycin, and vincristine in the treatment of AIDS-related Kaposi's sarcoma: results of a randomized phase III clinical trial.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3031692

21 June 2018

Acute lymphocytic leukaemia in the elderly: characteristics and outcome with the vincristine-adriamycin-dexamethasone (VAD) regimen

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3031692

21 June 2018

Acute lymphoblastic leukemia in the elderly: results of two different treatment approaches in 49 patients during a 25-year period.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3031692

21 June 2018

Efficacy of daunorubicin in the therapy of adult acute lymphocytic leukemia: a prospective randomized trial by cancer and leukemia group B

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3031692

21 June 2018

Continuous Infusion or Bolus Injection in Cancer Chemotherapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3031692

21 June 2018

Risk factors for doxorubicin-induced congestive heart failure

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3031692

21 June 2018

Cyclophosphamide, pegylated liposomal doxorubicin, vincristine and prednisone (CDOP) plus rituximab is effective and well tolerated in poor performance status elderly patients with non-Hodgkin's lymphoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3031692

31 October 2018

High-dose daunorubicin as liposomal compound (Daunoxome) in elderly patients with acute lymphoblastic leukemia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3031692

31 October 2018

Treatment of acute lymphoblastic leukemia in the elderly: an evaluation of interferon alpha given as a single agent after complete remission

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3031692

31 October 2018

VAD regimen in the treatment of resistant multiple myeloma: slow or fast infusion?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3031692

31 October 2018

Cellular and plasma kinetics of daunorubicin given by two methods of administration in a patient with acute leukemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/20971822

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinical evaluation of long-term, continuous-infusion doxorubicin

1 reference

https://pubmed.ncbi.nlm.nih.gov/20971822

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cellular pharmacokinetics of daunomycin administered as continuous intravenous infusion in the treatment of acute non-lymphocytic leukaemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/20971822

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treatment of acute lymphoblastic leukemia in adults with intensive induction, consolidation, and maintenance chemotherapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/20971822

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Results of the vincristine, doxorubicin, and dexamethasone regimen in adults with standard- and high-risk acute lymphocytic leukemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/20971822

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Acute lymphoblastic leukemia in the elderly

1 reference

https://pubmed.ncbi.nlm.nih.gov/20971822

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Acute lymphoblastic leukemia in patients aged 60 years and over: a population-based study of incidence and outcome

1 reference

https://pubmed.ncbi.nlm.nih.gov/20971822

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Development of a new intensive therapy for acute lymphoblastic leukemia in children at increased risk of early relapse. The Memorial Sloan-Kettering-New York-II protocol

1 reference

https://pubmed.ncbi.nlm.nih.gov/20971822

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Acute lymphoblastic leukemia in patients over 59 years of age. Experience in a single center over a 10-year period

1 reference

https://pubmed.ncbi.nlm.nih.gov/20971822

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Age-adapted moderate-dose induction and flexible outpatient postremission therapy for elderly patients with acute lymphoblastic leukemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/20971822

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prognostic factors in elderly acute lymphoblastic leukaemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/20971822

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Age-adapted induction treatment of acute lymphoblastic leukemia in the elderly and assessment of maintenance with interferon combined with chemotherapy. A multicentric prospective study in forty patients. French Group for Treatment of Adult Acute Ly

1 reference

https://pubmed.ncbi.nlm.nih.gov/20971822

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Short course infusional idarubicin plus intermittent cytarabine and etoposide for refractory hematologic malignancies: clinical and preliminary pharmacological results

1 reference

https://pubmed.ncbi.nlm.nih.gov/20971822

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The use of cardiac biopsy to demonstrate reduced cardiotoxicity in AIDS Kaposi's sarcoma patients treated with pegylated liposomal doxorubicin

1 reference

https://pubmed.ncbi.nlm.nih.gov/20971822

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

[Analysis of elderly patients, aged 60 years old or over, with acute lymphoblastic leukemia]

1 reference

https://pubmed.ncbi.nlm.nih.gov/20971822

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Acute lymphoblastic leukemia in the elderly. A twelve-year retrospective, single center study

1 reference

https://pubmed.ncbi.nlm.nih.gov/20971822

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Acute lymphoblastic leukemia in the elderly: The Edouard Herriot Hospital experience

1 reference

https://pubmed.ncbi.nlm.nih.gov/20971822

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.3324/HAEMATOL.2010.027862

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

release_64jd4j6axbfmne6zbzltl6cd44

1 reference

https://api.fatcat.wiki/v0/release/64jd4j6axbfmne6zbzltl6cd44

24 November 2022

based on heuristic

mapped directly with Wikidata item

PMC publication ID

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33392436&oldid=1981670508"